Radiopharmaceuticals and Tracers

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

PET vs. SPECT, nuclear imaging advances

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both modalities also have suffered setbacks with radiopharmaceuti...

July 8, 2014 — NorthStar Medical Radioisotopes LLC has signed a pledge with the Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty...
June 17, 2014 — Navidea Biopharmaceuticals Inc. announced results from a post-hoc analysis of patient data from the company’s phase III clinical trial (NEO3-06...
June 16, 2014 — Piramal Imaging released details from research presented at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (...
June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept...
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the
Siemens Healthcare's syngo.via for molecular imaging is a reading solution that transforms large amounts of data into comprehensive results...
GE Healthcare's Discovery* IQ^ PET/CT (positron emission tomography/computed tomography) system enable both outstanding image quality and...

Articles

June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept...
myocardial perfusion, PET/CT, Siemens, Biograph, mCT
The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon...
Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify...
An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer contrast agent to be used with ...

Video Center

There were several new cardiovascular ultrasound technology advances highlighted at the American...
2 weeks 5 days ago
Call-backs have always been a problem in mammography. They are a source of worry, added discomfort...
3 weeks 5 days ago
There were several interesting studies coming out of the 2014 meeting for the Society of Nuclear...
4 weeks 4 days ago
This webinar will allow clinicians to learn more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available applications and technologies include...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
Lydia Liao spectral mammography
During this webinar, Lydia Liao,  M.D., Ph.D., M.P.H., presented an overview of contrast-enhanced spectral mammography technology and shared cases where SenoBright has...

Comparison Charts

Sorry there is no data available